Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

On Tuesday, a Broadalbin man with blood cancer was the first patient to receive a groundbreaking cancer treatment at a local ...

A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...